Che Yang | Specialist
Novo Nordisk

Che Yang is a specialist in protein engineering group at Novo Nordisk, with a particular focus on applying cutting-edge computational method and GenAI for design of mini-protein and antibody for the treatment of various diseases. He has been involved in scientific outreaching with emerging KOL in AI/ML field to strengthen the digital excellence of Novo Nordisk. He received his Ph.D. and post-doctoral training in Bioengineering from the Ecole Polytechnique Federale de Lausanne (EPFL), where he developed a strong background in the design and engineering of de novo protein for therapeutic use.